Association of Preoperative Hematocrit and Intraoperative/Postoperative Transfusion Volume With Outcomes of Major Abdominal Surgery
The American Surgeon™ · 2025
DOI: 10.1177/00031348251339533 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Surgeon™, 2025. Verfasst von Dariush Yalzadeh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Outcomes Research Laboratories (CORELAB), David Geffen School of Medicine at University of California, Los Angeles, CA, USA. Hauptthemen laut MEDLINE: Postoperative Complications, Blood Transfusion, Abdomen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Background
Despite the independent effect of lower preoperative hematocrit levels and higher transfusion volumes with increased postoperative morbidity and mortality, the impact of the interplay between these variables on outcomes remains poorly understood. We hypothesized that after adjusting for preoperative hematocrit, red cell transfusions exhibit a stepwise association with increased mortality and complications after major abdominal surgery (MAS).
Methods
All adults (≥18 years) undergoing elective MAS (colectomy, enterectomy, proctectomy, laparotomy, splenectomy, gastrectomy, enterorrhaphy/colorrhaphy, and peritoneal drainage) were identified in the 2020-2022 American College of Surgeons National Surgical Quality Improvement Program database. The primary outcome of interest was in-hospital mortality within 30 days of discharge. Secondary outcomes included postoperative complications, as well as length of stay (LOS) and unplanned readmission.
Results
Among 15,646 patients undergoing MAS, 88.0% were not transfused, while 5.3% received 1 unit and 6.7% received ≥2 units of blood. After multivariable adjustment, lower preoperative hematocrit levels (AOR 0.9, 95% Cl 0.9-1.0) and higher transfusion volumes (1 Unit: AOR 1.6, 95% Cl 1.1-2.4; ≥2 Unit: AOR 2.4, 95% Cl 1.6-3.4) were independently associated with an increased risk of mortality (all P < 0.05). Notably, higher transfusion volumes demonstrated a stronger association with increased rates of individual complications, prolonged LOS, and unplanned readmission compared to preoperative hematocrit levels (all P < 0.05).
Discussion
Given the independent impact of transfusion volume on acute outcomes, efforts should focus on early, multimodal anemia management to reduce transfusion requirements in the preoperative phase, rather than relying on intraoperative transfusions, when feasible.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiovascular Outcomes Research Laboratories (CORELAB), David Geffen School of Medicine at University of California, Los Angeles, CA, USA.
- Center for Advanced Surgical and Interventional Technology (CASIT), David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
- Department of Surgery, Harbor-UCLA Medical Center, Torrance, CA, USA.
- Department of Surgery, University of California, Los Angeles, CA, USA.
ORCID-Profile: Nam Yong Cho, Peyman Benharash
Zitieren
APA
Yalzadeh, D., Kwon, O. J., Cho, N. Y., Tabibian, K., Tabibian, D., Badiee, B., Chaturvedi, A., & Benharash, P. (2025). Association of Preoperative Hematocrit and Intraoperative/Postoperative Transfusion Volume With Outcomes of Major Abdominal Surgery. The American Surgeon™. https://doi.org/10.1177/00031348251339533
Vancouver
Yalzadeh D, Kwon OJ, Cho NY, Tabibian K, Tabibian D, Badiee B, et al. Association of Preoperative Hematocrit and Intraoperative/Postoperative Transfusion Volume With Outcomes of Major Abdominal Surgery. The American Surgeon™. 2025. doi:10.1177/00031348251339533
BibTeX
@article{Yalzadeh2025,
author = {Yalzadeh, Dariush and Kwon, Oh Jin and Cho, Nam Yong and Tabibian, Kevin and Tabibian, Daniel and Badiee, Barzin and Chaturvedi, Arjun and Benharash, Peyman},
title = {Association of Preoperative Hematocrit and Intraoperative/Postoperative Transfusion Volume With Outcomes of Major Abdominal Surgery},
journal = {The American Surgeon™},
year = {2025},
doi = {10.1177/00031348251339533}
}
EUVIMED